Shareholders to Vote on Company Dissolution and Liquidation
RBOTW sits 67% above its 52-week low of $0 on elevated volume (4.3× avg).
Summary
Vicarious Surgical Inc. has filed its definitive proxy statement, seeking shareholder approval to dissolve and liquidate the company, with common stockholders unlikely to receive any distributions.
Key Events · Corporate Governance and Compliance · RBOTW
-
Shareholder Vote on Dissolution
Shareholders will vote on July 21, 2026, to approve the assignment for the benefit of creditors, followed by a voluntary dissolution and liquidation of the company.
-
Unlikely Shareholder Distributions
The company explicitly states it is unlikely that common stockholders will receive any distributions from the liquidation process due to outstanding liabilities.
-
Cessation of Operations
Upon approval and completion of the dissolution, the company will cease all business activities except those related to winding up and liquidating its affairs.
-
Termination of Public Status
The company intends to terminate its status as a reporting company with the SEC upon completion of the assignment and dissolution, following its prior delisting from the NYSE.
Analysis · RBOTW · Industrial Applications And Services
This definitive proxy statement formalizes the company's plan to dissolve and liquidate, following previous disclosures of a going concern warning and NYSE delisting. The filing explicitly states that common stockholders are unlikely to receive any distributions, marking the end of the company as an operating entity and a complete loss for equity investors.
At the time of this filing, RBOTW was trading at $0.00 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.00 to $0.09. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.